FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Panel Backs Grail's Galleri Multi-Cancer Blood Test

An FDA advisory committee votes Wednesday to recommend approval of Grail's Galleri multi-cancer early detection blood test, voting unanimously, 10-0, ...

latest-news-card-1
Human Drugs

Improve Substantial Effectiveness Draft Guidance: Stakeholders

Four major stakeholders give numerous suggestions for significantly changing or improving an FDA draft guidance that revises the agencys approach to d...

Human Drugs

Proteomic Biomarker Framework to Speed Drug Development

An FDA online post explains the benefits of CDER scientists work in proteomics-based biomarker discovery.

latest-news-card-1
Human Drugs

FDA Accepts Wearable Sensor-Based Foot Drop Measure for Trials

FDA accepts a letter of intent for a wearable sensor-based digital outcome measure designed to assess foot drop severity and gait impairment in patien...

latest-news-card-1
FDA General

Gottlieb TV Appearance Endorses Overton FDA Nomination

Former FDA head Scott Gottlieb appears on CNBC to throw his support behind commissioner-nominee Heidi Overton on the eve of her Senate confirmation he...

latest-news-card-1
Medical Devices

Petition Seeks FDA Probe of Intuitive Surgical's da Vinci Device

A citizen petition seeks a safety investigation and potential recall of Intuitive Surgical's da Vinci Permanent Cautery Spatula, citing reports of mec...

latest-news-card-1
FDA General

Senate Urged to Question Overton on FDA's Scientific Decision-Making

FDA Matters blog author Steven Grossman urges the Senate HELP Committee to examine how FDA commissioner-nominee Heidi Overton intends to make regulato...

latest-news-card-1
Biologics

FDA Wants New Survival Trial Before Compass Files Tovecimig BLA

FDA recommends that Compass Therapeutics conduct an additional clinical trial demonstrating an overall survival benefit before submitting a BLA for to...

latest-news-card-1
Human Drugs

FDA: Empower Pharmacy Illegally Compounding GLP-1s

FDA warns Houston, TX-based Empower Pharmacy that it is illegally compounding GLP-1 drugs under conditions that violate CGMP regulations.

latest-news-card-1
Medical Devices

Study: AI-Assisted Device Reviews Could Reduce Recalls

A new study finds that a machine learning-based approach to FDA's 510(k) medical device clearance process could reduce device recalls by nearly one-th...